{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:47Z","timestamp":1753890527885,"version":"3.41.2"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the methodology quality, reporting quality, and evidence quality of systematic reviews and meta-analyses on Chinese patented oral medicines that promote blood circulation and remove blood stasis combined with conventional Western medicine in the treatment of coronary heart disease angina pectoris. The aim is to identify and address methodological issues in systematic reviews of Chinese patented oral medicines for promoting blood circulation and removing blood stasis in angina pectoris. This study also offers methodological guidance for future research design and implementation, and provides a basis for clinical decision-making.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was performed using CNKI, Wanfang, VIP, CBM, PubMed, Cochrane Library, Embase, and Web of Science databases, covering the period from the inception of each database to July 18, 2024, and meta-analyses on randomized controlled trials were included. Methodological quality was evaluated using AMSTAR-2, reporting quality using PRISMA 2020, and evidence quality of the outcome indicators using GRADE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty meta-analyses were examined, involving a total of 41,231 patients with angina pectoris. The methodological quality of all studies was rated as \u201ccritically low,\u201d with notable deficiencies in the registration of the study protocol, study inclusion criteria, assessment of individual study risk of bias, evaluation of the likelihood of publication bias, and discussion of the effects of publication bias on the results. The assessment of the three qualities mentioned above revealed common issues, including incomplete abstracts, lack of characteristics for pooled outcomes, failure to report risk of bias across studies, missing registration information, lack of accessibility details for protocols, and unreported modifications to registered protocols or plans. Evidence quality assessment revealed that 16 outcome indicators were rated as \u201cmoderate,\u201d 29 as \u201clow,\u201d and 46 as \u201cvery low.\u201d<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite the demonstrated efficacy and safety of Chinese patented oral medicines that promote blood circulation and remove blood stasis in the adjuvant treatment of angina pectoris, the low methodological and reporting quality of current systematic reviews and meta-analyses compromises the reliability of these findings. Future research should focus on standardizing study design and reporting to improve the reliability of evidence.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2025.1553735","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:23:29Z","timestamp":1750397009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Overview of systematic reviews on Chinese patented oral medicines for promoting blood circulation and removing blood stasis combined with western medicine in the treatment of coronary heart disease angina pectoris"],"prefix":"10.3389","volume":"12","author":[{"given":"Xinyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongli","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tcm.2021.04.002","article-title":"Coronary heart disease risk: low-density lipoprotein and beyond","volume":"32","author":"Shaya","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/477260a","article-title":"UN targets top killers","volume":"477","author":"Butler","year":"2011","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1161\/CIR.0000000000000746","article-title":"Correction to: heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"141","author":"Benjamin","year":"2020","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1408487","DOI":"10.3389\/fcvm.2024.1408487","article-title":"The incidence, mortality and disease burden of cardiovascular diseases in China: a comparative study with the United States and Japan based on the GBD 2019 time trend analysis","volume":"11","author":"Zhu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1471-2458-14-179","article-title":"The economic burden of angina on households in South Asia","volume":"14","author":"Alam","year":"2014","journal-title":"BMC Public Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1080\/07853890.2022.2078875","article-title":"Epidemiological analysis of coronary heart disease and its main risk factors: are their associations multiplicative, additive, or interactive?","volume":"54","author":"Voutilainen","year":"2022","journal-title":"Ann Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ajem.2016.12.070","article-title":"Anticoagulants in ischemia-guided management of non-ST-elevation acute coronary syndromes","volume":"35","author":"Mayer","year":"2017","journal-title":"Am J Emerg Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1093\/eurheartj\/ehx421","article-title":"Chronic refractory angina pectoris: recent progress and remaining challenges","volume":"38","author":"Waltenberger","year":"2017","journal-title":"Eur Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"CD004474","DOI":"10.1002\/14651858","article-title":"Tongxinluo (tong xin luo or tong-xin-luo) capsule for unstable angina pectoris","volume":"2006","author":"Wu","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.19540\/j.cnki.cjcmm.20210322.501","article-title":"Meta-analysis of efficacy and safety of shexiang tongxin dripping pills combined with conventional therapy of coronary heart disease","volume":"46","author":"Pan","year":"2021","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.19540\/j.cnki.cjcmm.20210524.702","article-title":"Molecular mechanism of qishen yiqi dripping pills in treating myocardial ischemia:a study based on HIF-1 signaling pathway","volume":"46","author":"Gong","year":"2021","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.62347\/NWAZ5584","article-title":"Efficacy and safety of guanxin danshen dropping pills for the treatment of angina pectoris: a meta-analysis","volume":"17","author":"Yu","year":"2025","journal-title":"Am J Transl Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"114922","DOI":"10.1016\/j.jpba.2022.114922","article-title":"Clinical metabolomic analysis of danlou tablets with antioxidant effects for treating stable angina pectoris","volume":"219","author":"Li","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.19540\/j.cnki.cjcmm.20211118.501","article-title":"Clinical comprehensive evaluation of guanxin shutong capsules in treatment of coronary heart disease angina pectoris with heart blood stasis syndrome","volume":"47","author":"Cui","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1186\/s13063-021-05771-y","article-title":"Efficacy and safety of Chinese herbal medicine wen Xin granules for the treatment of unstable angina pectoris with yang deficiency and blood stasis syndrome: study protocol for a randomized controlled trial","volume":"22","author":"Tian","year":"2021","journal-title":"Trials"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9931826","DOI":"10.1155\/2021\/9931826","article-title":"Efficacy and safety of Xue-fu-zhu-yu decoction for patients with coronary heart disease: a systematic review and meta-analysis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jrsm.1530","article-title":"Bibliometric study of \u2018overviews of systematic reviews\u2019 of health interventions: evaluation of prevalence, citation and journal impact factor","volume":"13","author":"Lunny","year":"2022","journal-title":"Res Synth Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13020-022-00587-7","article-title":"Efficacy and mechanisms of traditional Chinese medicine for COVID-19: a systematic review","volume":"17","author":"Kang","year":"2022","journal-title":"Chin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e35405","DOI":"10.1097\/MD.0000000000035405","article-title":"Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: a meta-analysis and systematic review","volume":"102","author":"Feng","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1168730","DOI":"10.3389\/fcvm.2023.1168730","article-title":"Compound danshen dripping pills vs. nitrates for stable angina pectoris: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ajem.2020.01.045","article-title":"A meta-analysis for kuanxiong aerosol on the treatment of angina pectoris","volume":"38","author":"Zhuang","year":"2020","journal-title":"Am J Emerg Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphar.2020.00213","article-title":"Dazhu hongjingtian preparation as adjuvant therapy for unstable angina pectoris: a meta-analysis of randomized controlled trials","volume":"11","author":"Man","year":"2020","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Br Med J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"B27","first-page":"120","article-title":"Meta-analysis of the clinical effects and safety of yangxinshi tablets in the treatment of coronary heart disease and angina pectoris","volume":"15","author":"Zhu","year":"2018","journal-title":"China Medical Herald"},{"key":"B28","doi-asserted-by":"publisher","first-page":"996","DOI":"10.12102\/j.issn.1672-1349.2018.08.002","article-title":"Meta-analysis of the efficacy and safety of yangxinshi tablets in the treatment of coronary heart disease and angina pectoris","volume":"16","author":"Zhou","year":"2018","journal-title":"J Cardiovasc Cerebrovasc Dis Integr Trad Chin West Med"},{"key":"B29","first-page":"915","article-title":"Meta-analysis of di'ao Xin Xue kang capsules in the treatment of coronary heart disease and angina pectoris","volume":"20","author":"Zhang","year":"2018","journal-title":"Zhejiang Clin Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1097\/CM9.0000000000002059","article-title":"Meta-analysis of the clinical effects of yangxinshi tablets combined with conventional western medicine in the treatment of coronary heart disease and angina pectoris","volume":"17","author":"Zhang","year":"2022","journal-title":"China Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.13729\/j.issn.1671-7813.Z20211754","article-title":"Meta-analysis of randomized controlled trials on the efficacy of Xinmaitong in treating coronary heart disease and angina pectoris","volume":"36","author":"Yang","year":"2022","journal-title":"Pract J Intern Med"},{"key":"B32","first-page":"801","article-title":"Meta-analysis of the efficacy of tongxinluo capsules in the treatment of coronary heart disease and angina pectoris","volume":"21","author":"Wang","year":"2012","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.19540\/j.cnki.cjcmm.20201230.502","article-title":"Systematic evaluation of the efficacy and safety of Ginkgo Biloba dropping pills in the treatment of coronary heart disease and angina pectoris","volume":"46","author":"Wang","year":"2021","journal-title":"China J Tradit Chin Med"},{"key":"B34","first-page":"3272","article-title":"Meta-analysis of the clinical efficacy of guanxin danshen dropping pills in the treatment of coronary heart disease and angina pectoris","volume":"15","author":"Wang","year":"2020","journal-title":"World Tradit Chin Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.6039\/j.issn.1001-0408.2016.03.22","article-title":"Meta-analysis of the efficacy of yixinshu capsules as an adjunct therapy in the treatment of coronary heart disease and angina pectoris","volume":"27","author":"Tang","year":"2016","journal-title":"China Pharmacy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.19540\/j.cnki.cjcmm.20240219.501","article-title":"Meta-analysis and trial sequential analysis of shenshao capsules in the treatment of coronary heart disease and angina pectoris","volume":"49","author":"Sun","year":"2024","journal-title":"China J Tradit Chin Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.12102\/j.issn.1672-1349.2018.20.019","article-title":"Systematic review of Xueshuan Xinmaining in the treatment of qi deficiency and blood stasis type angina pectoris","volume":"16","author":"Ren","year":"2018","journal-title":"J Cardiovasc Cerebrovasc Dis Integr Tradit Chin West Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3969\/j.issn.1004-745X.2020.11.008","article-title":"Systematic review of shexiang baoxin pills combined with conventional western medicine in improving unstable angina pectoris in coronary heart disease","volume":"29","author":"Liu","year":"2020","journal-title":"China J Emerg Tradit Chin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3969\/j.issn.1004745X.2021.11.001","article-title":"Meta-analysis and GRADE evaluation of wenxin granules combined with conventional western medicine in the treatment of coronary heart disease and angina pectoris","volume":"30","author":"Liu","year":"2021","journal-title":"China J Emerg Tradit Chin Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.19540\/j.cnki.cjcmm.20221015.501","article-title":"Meta-analysis and GRADE evidence evaluation of guanxining tablets in the treatment of coronary heart disease and angina pectoris","volume":"48","author":"Li","year":"2023","journal-title":"China J Tradit Chin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.12102\/j.issn.1672-1349.2022.15.002","article-title":"Meta-analysis of the clinical efficacy of guanxining tablets in the treatment of coronary heart disease and angina pectoris","volume":"20","author":"Li","year":"2022","journal-title":"J Cardiovasc Cerebrovasc Dis Integr Tradit Chin West Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.14009\/j.issn.16722124.2019.12.023","article-title":"Systematic review of the efficacy and safety of naoxintong capsules in the treatment of coronary heart disease and angina pectoris","volume":"19","author":"Li","year":"2019","journal-title":"China Hospital Drug Eval Anal"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.13210\/j.cnki.jhmu.20220420.001","article-title":"Meta-analysis of the clinical efficacy of liqi huoxue dropping pills in the treatment of coronary heart disease and angina pectoris","volume":"28","author":"Han","year":"2022","journal-title":"J Hainan Med College"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3969\/j.issn.1673-7202.2021.18.011","article-title":"Systematic review of the efficacy of naoxintong capsules in the treatment of coronary heart disease and angina pectoris based on randomized controlled trials","volume":"16","author":"Feng","year":"2021","journal-title":"World Tradit Chin Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.11656\/j.issn.1673-9043.2020.02.16","article-title":"Systematic review of the efficacy of shexiang tongxin dripping pills combined with conventional western medicine in improving angina pectoris in coronary heart disease","volume":"39","author":"Du","year":"2020","journal-title":"J Tianjin Univ Tradit Chin Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.13935\/j.cnki.sjzx.151001","article-title":"Systematic review of the effect of wenxin granules combined with western medicine on the efficacy and safety of coronary heart disease and angina pectoris","volume":"10","author":"Cao","year":"2015","journal-title":"World J Integr Tradit West Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3969\/j.issn.1673-5501.2011.03.014","article-title":"Development and improvement of systematic review Re-evaluation","volume":"6","author":"Yang","year":"2011","journal-title":"J Evid-Based Pediatr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2046-4053-1-7","article-title":"Why prospective registration of systematic reviews makes sense","volume":"1","author":"Stewart","year":"2012","journal-title":"Syst Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2018.01.003","article-title":"Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality","volume":"100","author":"Sideri","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.socscimed.2017.12.005","article-title":"Understanding and misunderstanding randomized controlled trials","volume":"210","author":"Deaton","year":"2018","journal-title":"Soc Sci Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"Br Med J"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e072428","DOI":"10.1136\/bmj-2022-072428","article-title":"Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: cross sectional meta-research study","volume":"379","author":"Nguyen","year":"2022","journal-title":"Br Med J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jclinepi.2013.01.005","article-title":"Effective writing and publishing scientific papers, part II: title and abstract","volume":"66","author":"Cals","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"B54","first-page":"64","article-title":"Writing an abstract for a research manuscript: providing an honest, succinct and complete summary","volume":"63","author":"Bavdekar","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/aje\/kwx344","article-title":"Association between risk-of-bias assessments and results of randomized trials in cochrane reviews: the ROBES meta-epidemiologic study","volume":"187","author":"Savovic","year":"2018","journal-title":"Am J Epidemiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-psych-010418-102803","article-title":"How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses","volume":"70","author":"Siddaway","year":"2019","journal-title":"Annu Rev Psychol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13643-016-0361-y","article-title":"Time to consider sharing data extracted from trials included in systematic reviews","volume":"5","author":"Wolfenden","year":"2016","journal-title":"Syst Rev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.117.028991","article-title":"Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease","volume":"136","author":"Berry","year":"2017","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/eurheartj\/9.suppl_n.4060","article-title":"Pathophysiology of unstable angina pectoris\u2013correlations with coronary angioscopic imaging","volume":"9","author":"Hombach","year":"1988","journal-title":"Eur Heart J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e004080","DOI":"10.1161\/JAHA.116.004080","article-title":"Angina and future cardiovascular events in stable patients with coronary artery disease: insights from the reduction of atherothrombosis for continued health (REACH) registry","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/07853890109002058","article-title":"C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris","volume":"33","author":"Koukkunen","year":"2001","journal-title":"Ann Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.2174\/1573403X15666190522100041","article-title":"Pragmatic analysis of dyslipidemia involvement in coronary artery disease: a narrative review","volume":"16","author":"Mih\u0103il\u0103","year":"2020","journal-title":"Curr Cardiol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpha.2014.04.002","article-title":"UPLC-Q-TOF\/MS based metabolomic profiling of serum and urine of hyperlipidemic rats induced by high fat diet","volume":"4","author":"Wu","year":"2014","journal-title":"J Pharm Anal"},{"key":"B64","first-page":"1679","article-title":"Interrelations entre dur\u00e9e d'angine de poitrine pr\u00e9existante, circulation de suppl\u00e9ance et fonction ventriculaire gauche apr\u00e8s occlusion coronaire isol\u00e9e avec ou sans infarctus myocardique [Relations of the duration of pre-existing angina pectoris, collateral circulation and left ventricular function after isolated coronary occlusion with or without myocardial infarction]","volume":"83","author":"Juilli\u00e8re","year":"1990","journal-title":"Arch Mal Coeur Vaiss"},{"key":"B65","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/BF00051191","article-title":"Oral nitroglycerin in angina pectoris\u2013evaluation of effect by computerized exercise testing using two different doses","volume":"2","author":"Kohli","year":"1988","journal-title":"Cardiovasc Drugs Ther"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4176518","DOI":"10.1155\/2017\/4176518","article-title":"Biotransformation of Dioscorea nipponica by rat intestinal Microflora and cardioprotective effects of diosgenin","volume":"2017","author":"Feng","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jep.2015.10.004","article-title":"Cardioprotective effect of total saponins from three medicinal species of Dioscorea against isoprenaline-induced myocardial ischemia","volume":"175","author":"Tang","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.2174\/1381612823666170822101112","article-title":"Danshen (Salvia miltiorrhiza bunge): a prospective healing sage for cardiovascular diseases","volume":"23","author":"Chen","year":"2017","journal-title":"Curr Pharm Des"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1142\/S0192415X18500878","article-title":"Pharmacological effects and mechanisms of Chinese medicines modulating NLRP3 inflammasomes in ischemic cardio\/cerebral vascular disease","volume":"46","author":"Li","year":"2018","journal-title":"Am J Chin Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jep.2018.08.029","article-title":"Network pharmacology study reveals energy metabolism and apoptosis pathways-mediated cardioprotective effects of shenqi fuzheng","volume":"227","author":"Liao","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"112859","DOI":"10.1016\/j.jep.2020.112859","article-title":"Identification of the active compounds and drug targets of Chinese medicine in heart failure based on the PPARs-RXR\u03b1 pathway","volume":"257","author":"Shao","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/biomedicines13010232","article-title":"Baicalin mitigates cardiac hypertrophy and fibrosis by inhibiting the p85a subunit of PI3K","volume":"13","author":"He","year":"2025","journal-title":"Biomedicines"},{"key":"B73","doi-asserted-by":"publisher","first-page":"111979","DOI":"10.1016\/j.biopha.2021.111979","article-title":"Traditional Chinese medicine as a therapeutic option for cardiac fibrosis: pharmacology and mechanisms","volume":"142","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1553735\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:23:44Z","timestamp":1750397024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1553735\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":73,"alternative-id":["10.3389\/fcvm.2025.1553735"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1553735","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"1553735"}}